Mayank Ajmera

An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States

J. Meyers, C. Bell, Mayank Ajmera, 2022, Lupus.

Real-world clinical outcomes of patients with myelofibrosis treated with ruxolitinib: a medical record review.

F. Passamonti, F. Heidel, R. Parikh, 2022, Future oncology.

A real-world study of treatment patterns among patients with osteoporotic fracture: analysis of a Japanese hospital database

J. Meyers, H. Hagino, Tzu-Chieh Lin, 2023, Archives of Osteoporosis.

Retrospective Analysis of the Burden of Illness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Versus Asthma in Commercially Insured US Patients

J. Meyers, Christopher F. Bell, Mayank Ajmera, 2023, Cureus.

Evaluating Real-World Characteristics of Patients With Advanced Urothelial Carcinoma Eligible for Avelumab Maintenance Therapy: A Multicountry Retrospective Medical Chart Review.

J. Cappelleri, J. Bellmunt, E. Esterberg, 2023, Clinical genitourinary cancer.

Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause

R. Kagan, Mayank Ajmera, S. Mancuso, 2023, Menopause.